Out-of-pocket costs for certain prescription drugs will rise considerably in 2015 for those who purchased coverage through the public exchanges last year as more exchange plans will be charging coinsurance payments of more than 30 percent compared to last year.

That's the finding of a study of exchange plans by Avalere Health, which examined data from the public exchange marketplace and from Covered California and New York State of Health.

Avalere looked at the costs that have been set for specialty medications used to treat life-threatening illnesses such as cancer, rheumatoid arthritis, or multiple sclerosis. It found the following increases in the percent of plans charging more than 30 percent for coinsurance compared to 2014:

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.